Hospital pediatrics
-
Hospital pediatrics · Nov 2021
Reducing Delays in a Pediatric Procedural Unit With Ultrasound-Guided Intravenous Line Insertion.
Delay in vascular access is a leading cause of procedure delay in our pediatric procedure and infusion center. Use of ultrasound decreases time to peripheral intravenous catheter (PIV) insertion; however, ultrasound availability in our center was limited to an external venous access team (VAT). The objective of this project was to reduce PIV-related delays by 25%. ⋯ Unit-based USgPIV placement in a pediatric procedural center was successfully implemented, with a significant decline in procedures delayed by PIV access.
-
Hospital pediatrics · Oct 2021
Factors Associated With Bronchiolitis Guideline Nonadherence at US Children's Hospitals.
The objective with this study was to explore factors associated with nonadherence to national bronchiolitis guidelines at 52 children's hospitals. ⋯ Multiple factors are associated with national bronchiolitis guideline nonadherence.
-
Hospital pediatrics · Jul 2021
Accuracy of Diagnostic Codes for Identifying Brief Resolved Unexplained Events.
To evaluate International Classification of Diseases, 10th Revision (ICD-10) coding strategies for the identification of patients with a brief resolved unexplained event (BRUE). ⋯ The BRUE ICD-10 code and/or the diagnostic codes for the characteristics of BRUE are recommended, but the choice between approaches depends on the investigative purpose and the specific BRUE population and setting of interest.
-
The coronavirus disease 2019 (COVID-19) pandemic has impacted hospitals, potentially affecting quality and safety. Our objective was to compare pediatric hospitalization safety events during the pandemic versus previous years. ⋯ Postoperative sepsis rates increased among children hospitalized during COVID-19. Efforts are needed to improve safety of postoperative care for hospitalized children.
-
Hospital pediatrics · Mar 2021
Use of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days.
Recent evidence suggests that measuring the procalcitonin level may improve identification of low-risk febrile infants who may not need intervention. We describe outcomes after the implementation of a febrile infant clinical pathway recommending measurement of the procalcitonin level for risk stratification. ⋯ Clinicians quickly adopted procalcitonin testing. Resource use for low-risk infants decreased; however, there was no change to resource use for the overall population because more infants underwent laboratory evaluation and were classified as high risk post-PI.